Article Details
Retrieved on: 2024-04-24 19:31:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The data readouts from the Phase III (DAPA-MI) study of FARXIGA/FORXIGA are anticipated by 2H 2023, according to AstraZeneca's Q32022 investor ...
Article found on: www.barchart.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here